Why Remedy Health Media Is Buying OBR Oncology

By Annie Baker ● September 27, 2020
  • Digital health platform company Remedy Health Media recently announced the acquisition of Oncology Business Review (OBR). These are the details.

Digital health platform company Remedy Health Media recently announced the acquisition of Oncology Business Review (OBR), which is an oncology-focused digital media company that provides news and information resources to oncologists and oncology healthcare professionals (HCPs). OBR is considered a leading resource for the entire oncology team, reaching an audience of over 25,000 members daily.

Combining OBR’s leadership position in the oncology space with Remedy’s broad reach and resources creates an opportunity to grow both audience and impact across the oncology landscape. And OBR extends the company’s existing network of trusted digital health brands for consumers and healthcare professionals.

As the oncology landscape continues to evolve with significant advancements in treatment and patient care rooted in research, the acquisition of OBR is providing Remedy with a powerful platform to educate, raise awareness of research advancements, and play an important role in the dialogue between patients and professionals.

As an innovative healthcare media company, OBR is going to help strengthen Remedy’s overall HCP capabilities through its vast network of relevant key opinion leaders, market access training platform, and range of digital media resources delivering current and relevant oncology information.

KEY QUOTES:

“The addition of OBR allows Remedy to serve the oncology community in powerful ways by providing instant access to leading opinions and the most current medical information for oncology professionals. Aligning ourselves with innovative partners like OBR, which has been serving the oncology community for more than a decade, helps us amplify our mission and motivate communities of patients and professionals towards optimal patient care.” Cunnion added, “We are excited to welcome the terrific OBR team to Remedy.”
— Remedy CEO Mike Cunnion

“OBR has been serving the oncology community for more than 13 years, and our brand and presence amongst oncology providers and professionals is strong. We were well poised for a partner that would help us become even stronger in the creation and delivery of actionable oncology information. In Remedy, we have found a partner with a track record of success in creating and publishing important healthcare information, a robust digital presence, and the resources to help us maximize our potential.”
— OBR founder and president Don Sharpe

“As a leading authority in oncology news for healthcare professionals with unparalleled relationships across oncology stakeholders, the acquisition of OBR provides both a distinctive and fundamental platform to help Remedy grow and further serve its audience and partners.”
— Leigh Randall, Managing Partner at Topspin Consumer Partners